Health Condition 1: N859- Noninflammatory disorder of uterus, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 40 to 70 years belonging to ASA physical status I and II scheduled for elective total abdominal hysterectomy under combined spinal epidural anaesthesia and willing to provide written informed consent.
Exclusion criteria
Exclusion criteria: Patient refusal Coagulopathy or bleeding disorders Infection at injection site Known allergy to bupivacaine, magnesium sulfate, or fentanyl Severe cardiac renal or hepatic disease Patients receiving calcium channel blockers or magnesium therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of postoperative analgesia following epidural administration of study drugs.Timepoint: From epidural drug administration to first request for rescue analgesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of onset of analgesiaTimepoint: From epidural drug administration to achievement of VAS score less than or equal to 2;Pain intensity using Visual Analogue ScaleTimepoint: At 0, 2, 5, 10, 20, 30, 60 minutes and hourly for 6 hours post epidural topup;Hemodynamic parameters heart rate, blood pressure, oxygen saturationTimepoint: Before epidural topup and at 0, 2, 5, 10, 20, 30, 60 minutes and hourly for 6 hours post epidural topup;Incidence of adverse effects like nausea, vomiting, hypotension, pruritis, respiratory depressionTimepoint: During first 24 hours postoperative period | — |
Countries
India
Contacts
Shivamogga Institute of Medical Sciences